Dynamic Stem Cell Therapy offers regenerative medicine
A serious car accident left Mike Licata with a debilitating injury to his left shoulder.
My injury was so severe, and the pain was unbelievably intense, Licata said. It interfered with every part of my life.
Looking for alternatives to invasive surgery, Licata discovered Dynamic Stem Cell Therapy.
Traditional surgery was going to be around $75,000, with three months in a cast, a year-plus of rehab, and probably $120,000 out of pocket, Licata said. I was in trouble, then a friend told me about stem cell therapy.
Dynamic Stem Cell Therapy specializes in regenerative medicine, using stem cells to initiate healing within the body.
Stem cells are the building blocks of the human body, Dynamic Co-founder and Chief Executive Officer Blake Youmans said. They act as a booster of healthy cells for the body to heal itself. When were giving this therapy, its to potentially reverse the trauma that has been sustained. Its basically to help give patients a better quality of life.
Licatas treatment involved a quick injection of his own stem cells into the injury site, harvested from his fat tissue through syringe aspirated mini liposuction. The entire procedure took approximately four hours from Licata entering the clinic.
They did their magic, Licata said. This was so easy. It doesnt compare to invasive surgery.
Within months of the stem cell therapy, Licatas shoulder was completely healed, and his quality of life was restored.
Now, its better than my other shoulder, Licata said. I cant tell you how much this has changed my life.
Licata is one of thousands of patients discovering regenerative medicine at Dynamic Stem Cell Therapy.
The revolutionary regenerative technique works for a variety of conditions and diseases.
We focus mainly on athletic trauma, Youmans said. And inflammatory diseases, such as arthritis and rheumatoid arthritis but it is a way to fix the entire body.
The minimally invasive procedure offers patients an alternative to surgery. Youmans noted his procedure is safe and effective with no reported side effects, and his patients notice a difference in as little as two weeks or up to only six months after injection.
Its really up to a patients own body to heal themselves, Youmans said. Its a great alternative to try before surgery.
The staff at Dynamic obtain stems cells from two different sources: in the office from a patients own fat cells through mini liposuction or from the donated umbilical cord of a newborn. Young mothers, between the ages of 18 and 35 are prescreened and provide authorization for the collection. A lab collects the umbilical cord after birth, and its stem cells are harvested and sold.
After age 65, our stem cell count goes way down, Youmans said. So, for older patients, I tell them it may be more effective to use zero-age stem cells for specific conditions.
Dynamic Stem Cell Therapy clinic has performed over 1,000 procedures over the last seven years. The success rate for patient outcomes averages from 75 to 100 percent.
Weve seen 98 percent success with knees, Youmans said. I feel good about what were doing helping patients get the results they want.
Regenerative medicine is successful in most patients, but the therapy has no guarantee of success. According to Youmans, all patients are thoroughly informed about that possibility before the therapy.
Ill bend over backward to make sure a patient gets a great result, Youmans said. But we cant guarantee anything or promise fast results.
The average cost of the treatment is $5,000 and is not covered by insurance. This price can still save patients thousands of dollars compared to surgery and follow-up rehabilitation.
Founded by Blake Youmans late mother, Simong Youmans, M.D. (an experienced Board- Certified Emergency Medicine Physician), Dynamic Stem Cell Therapy opened its doors in 2014.
Dr. Simong Youmans passion for helping people heal naturally, and, strengthening the bodys own defenses, led her to open several evidence-based alternative medicine businesses over the years. They include Elite Medical Services & Spa. Laser Body Sculpting Institute, Attitude Med Spa, Advanced Health, and, of course, Dynamic Stem Cell Therapy.
She thought there was a better way to help patients, Blake Youmans said. So, she found natural solutions to help them heal themselves.
Blake Youmans began working alongside his mother in 2004 and witnessed the benefits experienced through regenerative medicine. Following her passing in 2016, he chose to continue what his mother started at Dynamic Stem Cell Therapy.
I want to continue her legacy, he said. My mom really believed stem cell therapy was the best way to help people. Its been incredible.
The 2,500-square-foot clinic at 2551 North Green Valley Parkway in Henderson has a staff of six. It has grown significantly over the years strictly using reputation marketing.
Right now, I have almost 100 reviews on Google, Blake Youmans said. Out of those 100 reviews, theyre mostly five stars, so I take great pride in that because, at the end of the day, all I care about is good patient outcomes.
Dr. Dale Carrison, DO, FACEP, FACOEP is Dynamics medical director. He served at several of the valleys prestigious medical organizations, and most recently as director and chairman of the Department of Emergency Medicine at University Medical Center (UMC).
He has a great reputation in town, Blake Youmans said. I feel very blessed to have him as my medical director.
Carrison came on staff after experiencing regenerative stem cell therapy himself. His procedure performed at Dynamic involved having his own stem cells injected into his ankles.
He said it felt like he was walking on glass, Blake Youmans said about Carrisons injury. He got the procedure done and four months later his ankles felt great.
Now, he comes from a better place of empathy for patients, Blake Youmans continued. When hes doing consults, he can say how it went for him.
Blake Youmans plans to expand into other markets once things start opening back up from the pandemic.
My mothers vision was to help as many people as she could, he said. I can only do so much in Las Vegas, so I would like to go into other markets to help more people.
Members of the editorial and news staff of the Las Vegas Review-Journal were not involved in the creation of this content.
More here:
Dynamic Stem Cell Therapy Offers Regenerative Medicine - Las Vegas Review-Journal
- The therapeutic potential of stem cells - PubMed Central (PMC) - November 12th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 18th, 2024
- Doctor who provided ineffective stem cell therapies disciplined 6 years after investigation began - CBS Chicago - October 15th, 2024
- Study reveals the benefits and downside of fasting - Big Think - September 28th, 2024
- Tiny vesicles from umbilical cord blood may have therapeutic benefit - Parkinson's News Today - September 28th, 2024
- The Stem Cell Solution Review: Is This Program the Future of Anti-Aging and Recovery? - Enumclaw Courier-Herald - September 28th, 2024
- Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center - Technology Networks - September 25th, 2024
- Stem Cell Restore: A Full Review of Its Role in Promoting Regeneration and Vitality - Islands' Sounder - September 18th, 2024
- Is fasting good for you? A new study reveals some hidden risks and benefits of the practice - Business Insider India - August 31st, 2024
- Study reveals the benefits and downside of fasting - MIT News - August 27th, 2024
- Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain - August 22nd, 2024
- Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Niclas Lindstedt - August 22nd, 2024
- PharmaTher’s Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins - August 22nd, 2024
- BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY... - August 22nd, 2024
- Eyenovia Announces Pricing of $5.14 Million Public Offering - August 22nd, 2024
- Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management... - August 22nd, 2024
- Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment - August 22nd, 2024
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® - August 22nd, 2024
- MDxHealth Reports Q2 and Half Year 2024 Results - August 22nd, 2024
- Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country - August 22nd, 2024
- Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of... - August 22nd, 2024
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility - August 22nd, 2024
- Certara to Participate in Upcoming Investor Conferences - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Satu Ahomäki - August 22nd, 2024
- Bavarian Nordic Announces First Half 2024 Results - August 22nd, 2024
- BioCryst to Present at Upcoming Investor Conferences - August 22nd, 2024
- Zymeworks Announces Participation in Upcoming Investor Conferences - August 22nd, 2024
- MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - August 14th, 2024
- Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan - August 14th, 2024
- Shock Top and Gator Athletics Partner to Introduce First-Ever Craft Beer Sponsorship of the Florida Athletic Department - August 14th, 2024
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update - August 14th, 2024
- Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - August 14th, 2024
- Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders - August 14th, 2024
- Evaxion Announces Business Update and Second Quarter 2024 Financial Results - August 14th, 2024
- Galera Announces Board Approval of Complete Liquidation and Dissolution - August 14th, 2024
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update - August 14th, 2024
- Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - August 14th, 2024
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - August 14th, 2024
- CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update - August 14th, 2024
- Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine - August 14th, 2024
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - August 14th, 2024
- Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005 - August 14th, 2024
- Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic... - August 14th, 2024
- Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results - August 14th, 2024
- Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - August 14th, 2024
- Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis - August 14th, 2024
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates... - August 14th, 2024
- What Is Stem Cell Therapy? How Does It Work? - ThePrint - August 6th, 2024
- New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear - Managed Healthcare Executive - July 26th, 2024
- Cord Blood Awareness Month: Advantages of cord blood banking, things to keep in mind - Moneycontrol - July 10th, 2024
- Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System - Frontiers - June 28th, 2024
- Harnessing benefits of stem cells for heart regeneration | ASU News - ASU News Now - June 21st, 2024
- 'Didn't know this would be possible': Autistic teen's mom on stem cell therapy benefits - WZTV - May 6th, 2024
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
Recent Comments